Pfizer Inc makes an aromatase inhibitor called exemestane, which it sells under the brand Aromasin, and AstraZeneca Plc makes anastrozole, sold under the ...
For example, Saskatchewan doesn't pay for Arimidex, Femara and Aromasin to treat breast cancer, but they are fully funded in BC and Alberta. ...
... account for the majority of private claims and costs: Xeloda, Temodol, Gleevec, Tarceva and three aromatase inhibitors: Femara, Aromasin and Arimidex. ...
For example, Saskatchewan doesn't pay for Arimidex, Femara and Aromasin to treat breast cancer but they are fully funded in BC and Alberta. ...
Dr. Eisen says the drug, called exemestane (Aromasin), lowers estrogen levels by more than 95-percent. "Higher levels of estrogen have been linked to ...
Zujewski notes that in the US, aromatase inhibitors (such as Femara, Arimidex, or Aromasin) -- not tamoxifen -- are now a mainstay of hormonal treatment for ...
Pfizer Inc. (NYSE: PFE | charts | news | PowerRating) also makes an aromatase inhibitor called exemestane, which it sells under the brand name Aromasin, ...
Pfizer Inc. (NYSE: PFE | charts | news | PowerRating) also makes an aromatase inhibitor called exemestane, which it sells under the brand name Aromasin, ...
However, newer drugs called aromatase inhibitors, which include Arimidex as well as Novartis AG's (NVS) Femara and Pfizer Inc's (PFE) Aromasin, ...
Pfizer Inc also makes an aromatase inhibitor called exemestane, which it sells under the brand name Aromasin, and Novartis makes one called letrozole or ...